Arginine as a crucial amino acid in carcinogenesis and tumor growth;Arginina - podstawowy aminokwas w procesie nowotworzenia

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 60, Issue , 2006, Pages 483-489

  Graboń, Wojciech ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Angiogenesis; Apoptosis; Arginase; Arginine; Carcinogenesis; Methylarginines; Nitric oxide; Polyamines; Tumor growth

Indexed keywords

ARGININE;

ADULT; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL TRANSFORMATION; CHILD; DISEASE COURSE; HUMAN; IN VITRO STUDY; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; ANIMALS; APOPTOSIS; ARGININE; BIOLOGICAL TRANSPORT; CELL TRANSFORMATION, NEOPLASTIC; CHILD; DISEASE PROGRESSION; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 39049188625     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Ascierto P.A., Scala S., Castello G., Daponte A., Simeone E., Ottaiano A., Beneduce G., De Rosa V., Izzo F., Melucci M.T., Ensor C.M., Prestayko A.W., Holtsberg F.W., Bomalaski J.S., Clark M.A., Savaraj N., Feun L.G., Logan T.F.: Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J. Clin. Oncol., 2005; 23: 7660-7668
2. Cadoret A., Ovejero C., Terris B., Souil E., Levy L., Lamers W.H., Kitajewski J., Kahn A., Perret C.: New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene, 2002; 21: 8293-8301
3. Caso G., McNurlan M.A., McMillan N.D., Eremin O., Garlick P.J.: Tumour cell growth in culture: dependence on arginine. Clin. Sci., 2004; 107: 371-379
4. Cederbaum S.D., Yu H., Grody W.W., Kern R.M., Yoo P., Iyer R.K.: Arginases I and II: do their functions overlap? Mol. Genet. Metab., 2004; 81(Suppl.1): S38-S44
5. Cendan J.C., Souba W.W., Copeland E.M.3rd, Lind D.S.: Characterization and growth factor stimulation of L-arginine transport in a human colon cancer cell line. Ann. Surg. Oncol., 1995; 2: 257-265
6. Cendan J.C., Souba W.W., Copeland E.M. III, Lind D.S.: Increased L-arginine transport in a nitric oxide-producing metastatic colon cancer cell line. Ann. Surg. Oncol., 1996; 3: 501-508
7. Cheng P.N., Leung Y.C., Lo W.H., Tsui S.M., Lam K.C.: Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma. Cancer Lett., 2005; 224: 67-80
8. Cianchi F., Cortesini C., Fantappie O., Messerini L., Schiavone N., Vannacci A., Nistri S., Sardi I., Baroni G., Marzocca C., Perna F., Mazzanti R., Bechi P., Masini E.: Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am. J. Pathol., 2003; 162: 793-801
9. Curley S.A., Bomalaski J.S., Ensor C.M., Holtsberg F.W., Clark M.A.: Regression of hepatocellular cancer in a patient treated with arginine deiminase. Hepatogastroenterology, 2003; 50: 1214-1216
10. Dillon B.J., Prieto V.G., Curley S.A., Ensor C.M., Holtsberg F.W., Bomalaski J.S., Clark M.A.: Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: A method for identifying cancers sensitive to arginine deprivation. Cancer, 2004; 100: 826-833
11. Ensor C.M., Holtsberg F.W., Bomalaski J.S., Clark M.A.: Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res., 2002; 62: 5443-5450
12. Felig P.: Amino acid metabolism in man. Annu. Rev. Biochem., 1975; 44: 933-955
13. Flynn N.E., Meininger C.J., Haynes T.E., Wu G.: The metabolic basis of arginine nutrition and pharmacotherapy. Biomed. Pharmacother., 2002; 56: 427-438
14. Gokmen S.S., Aygit A.C., Ayhan M.S., Yorulmaz F., Gulen S.: Significance of arginase and ornithine in malignant tumors of the human skin. J. Lab. Clin. Med., 2001; 137: 340-344
15. Gotoh H., Araki M., Mori M.: Chromosomal localization of the human arginase II gene and tissue distribution of its mRNA. Biochem. Biophys. Res. Comm., 1997; 233: 487-491
16. Harris B.E., Pretlow T.P., Bradley E.L.Jr, Whitehurst G.B., Pretlow T.G. II: Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma. Cancer Res., 1983; 43: 3008-3012
17. Huang S., Trujillo J.M., Chakrabarty S.: Proliferation of human colon cancer cells: role of epidermal growth factor and transforming growth factor alpha. Int. J. Cancer, 1992; 52: 978-986
18. Huang Y., Hager E.R., Phillips D.L., Dunn V.R., Hacker A., Frydman B., Kink J.A., Valasinas A.L., Reddy V.K., Marton L.J., Casero R.A.Jr, Davidson N.E.: A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells. Clin. Cancer Res., 2003; 9: 2769-2777
19. Ikemoto M., Tsunekawa S., Awane M., Fukuda Y., Murayama H., Igarashi M., Nagata A., KasaiY., Totani M.: A useful ELISA system for human liver-type arginase, and its utility in diagnosis of liver diseases. Clin. Biochem., 2001; 34: 455-461
20. Izzo F., Marra P., Beneduce G., Castello G., Vallone P., De Rosa V., Cremona F., Ensor C.M., Holtsberg F.W., Bomalaski J.S., Clark M.A., Ng C., Curley S.A.: Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. J. Clin. Oncol., 2004; 22: 1815-1822
21. Klotz T., Bloch W., Volberg C., Engelmann U., Addicks K.: Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer, 1998; 82: 1897-1903
22. Kojima M., Morisaki T., Tsukahara Y., Uchiyama A., Matsunari Y., Mibu R., Tanaka M.: Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J. Surg. Oncol., 1999; 70: 222-229
23. Kostourou V., Robinson S.P., Cartwright J.E., Whitley G.S.: Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis. Br. J. Cancer, 2002; 87: 673-680
24. Kostourou V., Robinson S.P., Whitley G.S., Griffiths J.R.: Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging. Cancer Res., 2003; 63: 4960-4966
25. Kostourou V., Troy H., Murray J.F., Cullis E.R., Whitley G.S., Griffiths J.R., Robinson S.P.: Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo. Neoplasia, 2004; 6: 401-411
26. Lagares-Garcia J.A., Moore R.A., Collier B., Heggere M., Diaz F., Qian F.: Nitric oxide synthase as a marker in colorectal carcinoma. Am. Surg., 2001; 67: 709-713
27. Lee J., Ryu H., Ferrante R.J., Morris S.M.Jr, Ratan R.R.: Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc. Natl. Acad. Sci. USA, 2003; 100: 4843-4848
28. Leiper J.M., Santa Maria J., Chubb A., MacAllister R.J., Charles I.G., Whitley G.S., Vallance P.: Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distribution and homology with microbial arginine deiminases. Biochem. J., 1999; 343: 209-214
29. Leu S.Y., Wang S.R.: Clinical significance of arginase in colorectal cancer. Cancer, 1992; 70: 733-736
30. Lind D.S.: Arginine and cancer. J. Nutr., 2004;134: 2837S-2841S
31. May T.S.: Military surveillance system for breast cancer detection. Drug Discov. Today, 2002; 7: 1111-1112
32. Miyasaka Y., Enomoto N., Nagayama K., Izumi N., Marumo F., Watanabe M., Sato C.: Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization. Br. J. Cancer, 2001; 85: 228-234
33. Morbidelli L., Donnini S., Ziche M.: Role of nitric oxide in tumor angiogenesis. Cancer Treat. Res., 2004; 117: 155-167
34. Ogawa T., Kimoto M., Sasaoka K.: Purification and properties of a new enzyme, NG, NG-dimethylarginine dimethylaminohydrolase from rat kidney. J. Biol. Chem., 1989; 264: 10205-10209
35. Philip R., Campbell E., Wheatley D.N.: Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures. Br. J. Cancer, 2003; 88; 613-623
36. Porembska Z., Luboiñski G., Chrzanowska A., Mielczarek M., Magnuska J., Barañczyk-Kuma A.: Arginase in breast cancer. Clin. Chim. Acta, 2003; 328: 105-111
37. Porembska Z., Mielczarek M., Nyckowski P., Barañczyk-Kuma A.: Arginase as a marker of cancerogenesis. I. Monitoring patients after resection of colorectal cancer. Pol. Merkuriusz Lek., 2002; 13: 284-285
38. Porembska Z., Nyckowski P., Skwarek A., Mielczarek M., Barañczyk-Kuma A.: Arginase a marker of cancerogenesis. II. Monitoring of patients after resection of colorectal liver metastases. Pol. Merkuriusz Lek., 2002; 13: 286-288
39. Porembska Z., Zabek J., Grabon W., Rahden-Staron I., Barañczyk-Kuma A.: Arginase isoforms in human colorectal cancer. Clin. Chim. Acta, 2001; 305: 157-165
40. Reveneau S., Arnould L., Jolimoy G., Hilpert S., Lejeune P., Saint-Giorgio V., Belichard C., Jeannin J.F.: Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab. Invest., 1999; 79:1215-1225
41. Salvucci O., Carsana M., Bersani I., Tragni G., Anichini A.: Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res., 2001; 61: 318-326
42. Schipper R.G., Deli G., Deloyer P., Lange W.P., Schalken J.A., Verhofstad A.A.: Antitumor analog of the polyamine analog N(1), N(11)-diethylnorspermine against human prostate carcinoma cells. Prostate, 2000; 44: 313-321
43. Scott L., Lamb J., Smith S., Wheatley D.N.: Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. Br. J. Cancer, 2000; 83: 800-810
44. Selamnia M., Robert V., Mayeur C., Delpal S., Blachier F.: De novo synthesis of arginine and ornithine from citrulline in human colon carcinoma cells: metabolic fate of L-ornithine. Biochim. Biophys. Acta, 1998; 1425: 93-102
45. Shen L.J., Lin W.C., Bellousow K., Shen W.C.: Resistance to the antiproliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Lett., 2003; 191: 165-170
46. Singh R., Pervin S., Karimi A., Cederbaum S., Chaudhuri G.: Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res., 2000; 60: 3305-3312
47. Singh R., Pervin S., Wu G., Chaudhuri G.: Activation of caspase 3 activity and apoptosis in MDA-MB-468 cells by N(omega)-hydroxy-L-arginine, an inhibitor of arginase, is not solely dependent on reduction in intracellular polyamines. Carcinogenesis, 2001; 22: 1863-1869
48. Takahashi Y., Mai M., Nishioka K.: Alpha-difluoromethylornithine induces apoptosis as well as anti-angiogenesis in the inhibition of tumor growth and metastasis in a human gastric cancer model. Int. J. Cancer, 2000; 85: 243-247
49. Takigawa M., Enomoto M., Nishida Y., Pan H.O., Kinoshita A., Suzuki F.: Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro. Cancer Res., 1990; 50: 4131-4138
50. Torok N.J., Higuchi H., Bronk S., Gores G.J.: Nitric oxide inhibits apoptosis downstream of cytochrome c release by nitrosylating caspase. Cancer Res., 2002; 62: 1648-1653
51. Wang J., Torbenson M., Wang Q., Ro J.Y., Becich M.: Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen. Urol. Oncol., 2003; 21: 117-122
52. Wasa M., Bode B.P., Souba W.W.: Adaptive regulation of amino acid transport in nutrient deprived human hepatomas. Am. J. Surg., 1996; 171: 163-169
53. Wheatley D.N., Campbell E.: Arginine deprivation, growth inhibition and tumour cell death:3. Deficient utilisation of citrulline by malignant cells. Br. J. Cancer., 2003; 89: 573-576
54. Wheatley D.N., Scott L., Lamb J., Smith S.: Single amino acid (arginine) restriction: growth and death of cultured HeLa and human diploid fibroblasts. Cell Physiol. Biochem., 2000; 10: 37-55
55. White M.F.: The transport of cationic amino acids across the plasma membrane of mammalian cells. Biochim. Biophys. Acta, 1985; 822: 355-374
56. Windmueller H.G., Spaeth A.E.: Source and fate of circulating citrulline. Am. J. Physiol., 1981; 241: E473-E480
57. Wu C.W., Chung W.W., Chi C.W., Kao H.L., Lui W.Y., P'eng F.K., Wang S.R.: Immunohistochemical study of arginase in cancer of the stomach. Virchows Arch., 1996; 428: 325-331
58. Wu G., Morris S.M. Jr.: Arginine metabolism; nitric oxide and beyond. Biochem. J., 1998; 336: 1-17
59. Xie K., Huang S., Dong Z., Juang S.H., Gutman M., Xie QW., Nathan C., Fidler I.J.: Transfection with inducible nitric oxide synthase gene supresses tumorogenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med., 1995; 181: 1333-1343
60. Yu H., Yoo P.K., Aguirre R., Tson R., Kern R.M., Grody W.W., Cederbaum S.D., Iyer R.K.: Widespread expression of arginase I in mouse tissues: biochemical and physiological implications. J. Histochem. Cytochem., 2003; 51: 1151-1160
61. Ziche M., Morbidelli L.: Nitric oxide and angiogenesis. J. Neurooncol., 2000; 50: 139-148